Bryan Witherbee, CEO of Adarza Biosystems discusses ZIVA™, a label-free protein detection platform that can accurately test 100s of protein from a single drop of blood in a time and cost-efficient manner. While the initial launch of ZIVA was focused on biomarker detection in cancer, they have changed direction to assist in vaccine development and immunosurveillance following COVID-19 and they are now applying this technology in the quantification of SARS-CoV-2/COVID-19 antibodies and other upper respiratory pathogens.
#ZIVA #ProteinDetection
Visit our website
www.healtprofessionalradio.com.au
Follow us on our social media channels
Facebook: / hprfm
Twitter: / healthproradio
Google+: https://plus.google.com/+HealthProfes...
Pinterest: / healthprora. .
Linkedin: / heal. .
Instagram: / healthprofe. .
Subscribe to our podcast channels
Soundcloud: / healthprofessi. .
Itunes: https://itunes.apple.com/nz/podcast/h...
Support us on Patreon
/ hpr